Structural Analysis of the Role of Pseudomonas Aeruginosa Penicillin-binding Protein 5 in β-lactam Resistance
Overview
Authors
Affiliations
Penicillin-binding protein 5 (PBP5) is one of the most abundant PBPs in Pseudomonas aeruginosa. Although its main function is that of a cell wall dd-carboxypeptidase, it possesses sufficient β-lactamase activity to contribute to the ability of P. aeruginosa to resist the antibiotic activity of the β-lactams. The study of these dual activities is important for understanding the mechanisms of antibiotic resistance by P. aeruginosa, an important human pathogen, and to the understanding of the evolution of β-lactamase activity from the PBP enzymes. We purified a soluble version of P. aeruginosa PBP5 (designated Pa sPBP5) by deletion of its C-terminal membrane anchor. Under in vitro conditions, Pa sPBP5 demonstrates both dd-carboxypeptidase and expanded-spectrum β-lactamase activities. Its crystal structure at a 2.05-Å resolution shows features closely resembling those of the class A β-lactamases, including a shortened loop spanning residues 74 to 78 near the active site and with respect to the conformations adopted by two active-site residues, Ser101 and Lys203. These features are absent in the related PBP5 of Escherichia coli. A comparison of the two Pa sPBP5 monomers in the asymmetric unit, together with molecular dynamics simulations, revealed an active-site flexibility that may explain its carbapenemase activity, a function that is absent in the E. coli PBP5 enzyme. Our functional and structural characterizations underscore the versatility of this PBP5 in contributing to the β-lactam resistance of P. aeruginosa while highlighting how broader β-lactamase activity may be encoded in the structural folds shared by the PBP and serine β-lactamase classes.
Falcone M, Galfo V, Tiseo G Curr Opin Infect Dis. 2024; 37(6):594-601.
PMID: 39149832 PMC: 11556876. DOI: 10.1097/QCO.0000000000001044.
Lytic transglycosylase Slt of Pseudomonas aeruginosa as a periplasmic hub protein.
Avila-Cobian L, De Benedetti S, Hoshino H, Nguyen V, El-Araby A, Sader S Protein Sci. 2024; 33(7):e5038.
PMID: 38864725 PMC: 11168074. DOI: 10.1002/pro.5038.
Drug Discovery in the Field of β-Lactams: An Academic Perspective.
Jacobs L, Consol P, Chen Y Antibiotics (Basel). 2024; 13(1).
PMID: 38247618 PMC: 10812508. DOI: 10.3390/antibiotics13010059.
Penicillin-binding protein redundancy in enables growth during alkaline shock.
Mitchell S, Kearns D, Carlson E Appl Environ Microbiol. 2023; 90(1):e0054823.
PMID: 38126750 PMC: 10807460. DOI: 10.1128/aem.00548-23.
Resistance in : A Narrative Review of Antibiogram Interpretation and Emerging Treatments.
Giovagnorio F, De Vito A, Madeddu G, Parisi S, Geremia N Antibiotics (Basel). 2023; 12(11).
PMID: 37998823 PMC: 10669487. DOI: 10.3390/antibiotics12111621.